Zurich Cantonal Bank’s Voyager Therapeutics VYGR Stock Holding History

Zurich Cantonal Bank’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,126	Closed	-$10K	–	2622
2021 Q1	$10K	Hold	2,126	–	–	﹤0.01%	2541
2020 Q4	$15K	Hold	2,126	–	–	﹤0.01%	2591
2020 Q3	$23K	Hold	2,126	–	–	﹤0.01%	2471
2020 Q2	$27K	Hold	2,126	–	–	﹤0.01%	2404
2020 Q1	$19K	Hold	2,126	–	–	﹤0.01%	2358
2019 Q4	$30K	Hold	2,126	–	–	﹤0.01%	2387
2019 Q3	$37K	Hold	2,126	–	–	﹤0.01%	2222
2019 Q2	$58K	Buy	2,126 +1,675	+371%	+$38.3K	﹤0.01%	1971
2019 Q1	$9K	Sell	451 -974	-68%	-$12.7K	﹤0.01%	2519
2018 Q4	$13K	Hold	1,425	–	–	﹤0.01%	2527
2018 Q3	$27K	Hold	1,425	–	–	﹤0.01%	2406
2018 Q2	$28K	Sell	1,425 -1,558	-52%	-$30.8K	﹤0.01%	2355
2018 Q1	$56K	Buy	+2,983	New	+$64.5K	﹤0.01%	1987

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Zurich Cantonal Bank's VYGR Position: Q2 2021 in Review

Zurich Cantonal Bank sold out of Voyager Therapeutics (VYGR) in Q2 2021, closing a stake of 2,126 shares — an estimated $10K sold.

Zurich Cantonal Bank first reported a position in VYGR in Q1 2018 and held it in 13 quarters. The position peaked at $58K in Q2 2019. 78 funds tracked by Wall St. Rank hold VYGR as of Q2 2021.

Zurich Cantonal Bank reported no remaining Voyager Therapeutics position as of Q2 2021 after selling out during the quarter.
Zurich Cantonal Bank sold 2,126 Voyager Therapeutics shares in Q2 2021, an estimated $10K.
Zurich Cantonal Bank first reported a position in Voyager Therapeutics in Q1 2018 and held it in 13 quarters.
Zurich Cantonal Bank's Voyager Therapeutics position peaked at $58K in Q2 2019.
78 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2021.

Based on Zurich Cantonal Bank's 13F filing for Q2 2021, filed 30 Jul 2021.